On Wednesday, the EU’s top court said that a vaccine could be considered defective if there is “specific and consistent evidence,” including the time between a vaccine’s administration and the occurrence of a disease, the individual’s previous state of health, the lack of any family history of the disease and a significant number of reported cases of the disease occurring following vaccination.
Each chosen point listed by the court for its consideration spells bad news for the European vaccine industry. Ample evidence can be regularly found regarding a vaccination being the culprit for an individual’s slide into one of many specific ill-health conditions listed on the vaccine’s patient information leaflet. The EU court case was carryed over from a French case of a man who was immunized against hepatitis B in late 1998-99. About a year later Mr. J.W., as he is referred to in the documents, was diagnosed with multiple sclerosis. In 2006, he and his family sued vaccine-maker Sanofi Pasteur in an attempt to be compensated for the damage they claim he suffered due to the vaccine. Mr. J.W. died in 2011.
See more of this article at jeffereyjaxen.com